Quick Answer
Medicale Corp. reported Net Income Loss of -$41.2 thousand for the year ending 2025.
- Medicale Corp. showed an increase of +29.3% in Net Income Loss from 2024 to 2025.
- This data is from Medicale Corp.'s annual report (Form 10-K), filed with the SEC on January 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2020: -$11.5 thousand | Q1 2021: -$7.2 thousand | Q2 2021: -$6.9 thousand | Q4 2021: -$18.7 thousand | Q1 2022: -$6.6 thousand | Q2 2022: -$6.7 thousand | Q4 2022: -$8.3 thousand | Q1 2023: -$6.1 thousand | Q2 2023: -$8.5 thousand | Q4 2023: -$19.3 thousand | Q1 2024: -$11.6 thousand | Q2 2024: -$10.5 thousand | Q4 2024: -$16.7 thousand | Q1 2025: -$8.3 thousand | Q2 2025: -$5.5 thousand | Q4 2025: -$5.3 thousand.
- Over the full 6 years of available data (2020 to 2025), Medicale Corp.'s Net Income Loss has declined by 2,040.0%.
- Historical annual values: Fiscal year 2025: -$41.2 thousand | Fiscal year 2024: -$58.2 thousand | Fiscal year 2023: -$37.1 thousand | Fiscal year 2022: -$46.4 thousand | Fiscal year 2021: -$32.2 thousand | Fiscal year 2020: -$1.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: